BioAge Labs
BIOA
83 hedge funds and large institutions have $85.6M invested in BioAge Labs in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 9 closing their positions.
244% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 9
178% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 9
24% more funds holding
Funds holding: 67 → 83 (+16)
12% more capital invested
Capital invested by funds: $76.2M → $85.6M (+$9.4M)
1.22% more ownership
Funds ownership: 56.57% → 57.79% (+1.2%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.26M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$3.89M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.46M |
| 3 |
BlackRock
New York
|
+$2.3M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.1M |
| 5 |
CF
Cantor Fitzgerald
New York
|
+$806K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
-$5.46M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.96M |
| 3 |
RI
RTW Investments
New York
|
-$2.96M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.97M |
| 5 |
HHMI
Howard Hughes Medical Institute
Chevy Chase,
Maryland
|
-$428K |
BIOA Hedge Fund Activity: Q2 2025 in Review
83 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q2 2025, worth a combined $85.6M — up 12% from $76.2M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new BIOA positions and 9 closed out — a net gain of 16 holders — while 31 added to existing stakes and 9 trimmed.
The largest buyer was ADAR1 Capital Management, adding an estimated $3.89M. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $5.46M sold.
- 83 institutional investors held BioAge Labs (BIOA) as of Q2 2025, up from 67 in Q1 2025.
- Funds reported $85.6M of BioAge Labs stock for Q2 2025, up 12% quarter-over-quarter.
- 25 funds opened new BioAge Labs positions in Q2 2025 and 9 closed out, a net change of +16 holders.
- The largest BioAge Labs buyer in Q2 2025 was ADAR1 Capital Management, an estimated $3.89M added.
- The largest BioAge Labs seller in Q2 2025 was Suvretta Capital Management, an estimated $5.46M sold.
Based on aggregated 13F filings for Q2 2025.